Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Clinical trial NCT06046612 · UNKNOWN
Trial details
- NCT number
- NCT06046612
- Sponsor
- Maastricht University Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2024-08-13
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.